A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies is a dataset published in Cancer Discovery (2023). On theSindex it has a DataRank of 1.0, placing it in the top 19.9% of the data-sharing corpus. It has been cited 43 times, with 28 citing works in its 1-hop citation network.
Ranks in the top 20% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.568
From this paper's citation signal
Citation Network Contribution
0.452
From 19 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 28 citers.
National Cancer Institute
Grant: U01 CA217858
National Cancer Institute
Grant: U54 CA209997
NIH Office of the Director
Grant: S10 OD012351
NIH Office of the Director
Grant: S10 OD021764
National Cancer Institute
Grant: P30 CA013696
National Cancer Institute
Grant: P30 CA008748
NCI NIH HHS
Grant: U01 CA272610
NIH HHS
Grant: S10 OD032433
CureSearch for Children's Cancer
MeSH Terms